These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 29393466)
1. Upregulation of long non‑coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma. Bai JG; Tang RF; Shang JF; Qi S; Yu GD; Sun C Mol Med Rep; 2018 Apr; 17(4):5328-5335. PubMed ID: 29393466 [TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma. Jiao M; Ning S; Chen J; Chen L; Jiao M; Cui Z; Guo L; Mu W; Yang H Int J Oncol; 2020 Jun; 56(6):1455-1467. PubMed ID: 32236578 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition. Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034 [TBL] [Abstract][Full Text] [Related]
4. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway. Zhao S; Wang J; Qin C J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741 [TBL] [Abstract][Full Text] [Related]
5. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma. Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma. Liang Z; Zhu B; Meng D; Shen X; Li X; Wang Z; Li L Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015363 [TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
8. Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion. Li Z; Li J; Ji D; Leng K; Xu Y; Huang L; Jiang X; Cui Y Gene; 2018 Mar; 645():131-136. PubMed ID: 29246536 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients. Chen X; Liu L; Zhu W Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527 [TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis. Huang S; Qing C; Huang Z; Zhu Y Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598 [TBL] [Abstract][Full Text] [Related]
11. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma. Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439 [TBL] [Abstract][Full Text] [Related]
12. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma. Zou W; Wang Z; Wang F; Li L; Liu R; Hu M BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. Yoshikawa D; Ojima H; Iwasaki M; Hiraoka N; Kosuge T; Kasai S; Hirohashi S; Shibata T Br J Cancer; 2008 Jan; 98(2):418-25. PubMed ID: 18087285 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma. Yang XQ; Xu YF; Guo S; Liu Y; Ning SL; Lu XF; Yang H; Chen YX World J Gastroenterol; 2014 Apr; 20(14):4076-84. PubMed ID: 24744599 [TBL] [Abstract][Full Text] [Related]
15. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as. Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis. Huang Q; Liu L; Liu CH; You H; Shao F; Xie F; Lin XS; Hu SY; Zhang CH Asian Pac J Cancer Prev; 2013; 14(2):829-34. PubMed ID: 23621247 [TBL] [Abstract][Full Text] [Related]
17. LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer. Chen S; Wu H; Lv N; Wang H; Wang Y; Tang Q; Shao H; Sun C Biomed Pharmacother; 2016 Aug; 82():583-8. PubMed ID: 27470400 [TBL] [Abstract][Full Text] [Related]
18. SOX4 is associated with poor prognosis in cholangiocarcinoma. Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339 [TBL] [Abstract][Full Text] [Related]
19. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma. Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094 [TBL] [Abstract][Full Text] [Related]
20. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. Shimada M; Sugimoto K; Iwahashi S; Utsunomiya T; Morine Y; Imura S; Ikemoto T J Gastroenterol; 2010 Aug; 45(8):896-902. PubMed ID: 20379837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]